Cargando…
Severe Pulmonary Disease Caused by Mycolicibacter kumamotonensis
Severe Mycolicibacter kumamotonensis-pulmonary disease was diagnosed in a 68-year-old immunocompetent woman in Greece; the disease was initially treated as tuberculosis. The patient responded favorably to a new treatment regimen of azithromycin, amikacin, moxifloxacin, and linezolid. Complete sympto...
Autores principales: | Manika, Katerina, Kontos, Fanourios, Papavasileiou, Apostolos, Papaventsis, Dimitrios, Sionidou, Maria, Kioumis, Ioannis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920653/ https://www.ncbi.nlm.nih.gov/pubmed/33622489 http://dx.doi.org/10.3201/eid2703.191648 |
Ejemplares similares
-
A case of novel, rapidly-growing Mycolicibacter kumamotonensis infection in a patient with severe pulmonary disease treated in New York City
por: Weidmann, Maxwell D., et al.
Publicado: (2023) -
Occupational Exposure to Zoonotic Tuberculosis Caused by Mycobacterium caprae, Northern Greece, 2019
por: Papaventsis, Dimitrios, et al.
Publicado: (2021) -
Immunomodulatory effect of macrolides: At what cost?
por: Kipourou, Maria, et al.
Publicado: (2016) -
Tigecycline Pharmacokinetic and Pharmacodynamic Profile in Patients with Chronic Obstructive Pulmonary Disease Exacerbation
por: Kipourou, Maria, et al.
Publicado: (2023) -
The Impact of Pulmonary Arterial Pressure on Exercise Capacity in Mild-to-Moderate Cystic Fibrosis: A Case Control Study
por: Manika, Katerina, et al.
Publicado: (2012)